Asahi Kasei Medical
  • Site Map
  • Contact Us
  • Font size: Small
  • Font size: Medium
  • Font size: Large
  • Home
  • Our Approach to Business
  • Corporate Information
  • News
  • Products
  • Patients and Families

December 21, 2011
Asahi Kasei Corp.

Corporate

Integration of Asahi Kasei Kuraray Medical and Asahi Kasei Medical

Asahi Kasei Corp. will integrate its two core operating companies in the medical devices-related field, Asahi Kasei Kuraray Medical Co., Ltd. and Asahi Kasei Medical Co., Ltd., as of April 1, 2012.

As previously announced in our release dated August 3, 2011, Kuraray Co., Ltd. will transfer the entirety of its 7% holding in Asahi Kasei Kuraray Medical to Asahi Kasei Corp. on April 1, 2012. Asahi Kasei Kuraray Medical will thus become a wholly owned subsidiary of Asahi Kasei Corp. on that date.

The Asahi Kasei Group is focused on the further development and expansion of its health care operations, and determined that the integration of Asahi Kasei Kuraray Medical and Asahi Kasei Medical would establish the optimal configuration. The newly integrated company will further solidify its position as a leading global company, leveraging the world-class medical technologies of the two companies.

As a top-tier manufacturer of blood purification systems, the newly reborn Asahi Kasei Medical will continue to expand operations in artificial kidneys, therapeutic apheresis devices such as separators and adsorption columns, Sepacell™ leukocyte reduction filters, and Planova™ virus removal filters, while advancing the development of new products and promoting the widespread adoption of innovative therapeutic technologies.

Outline of the integration

Surviving company: Asahi Kasei Medical Co., Ltd.
Date of integration: April 1, 2012

Corporate profile of Asahi Kasei Medical (after integration)

Home office location: Tokyo, Japan
Paid-in capital: ¥3 billion
Ownership: 100% by Asahi Kasei Corp.
Employees: ≈ 2,220
Net sales: ¥55.1 billion (FY2010), ¥61 billion (FY2011 forecast)
Business line: Manufacture and sale of APS™ polysulfone-membrane artificial kidneys (dialyzers), Cellsorba™ leukocyte adsorption columns, Sepacell™ leukocyte reduction filters, Planova™ virus removal filters
Production sites: Oita, Japan; Nobeoka, Miyazaki, Japan; Hangzhou, Zhejiang Province, China

* This press release was issued by Asahi Kasei Corporation.

Top of page